NRT Smoking Cessation Aids in Hungary
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 2 Daily Average Nutrient Consumption per Capita 2000-2003
Table 3 Life Expectancy at Birth 2000-2005
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
Summary 1 OTC Healthcare Switches 2004-2005
3.3 Competitive Environment
Table 6 Ownership Structure of the Largest Local Companies 2005
Table 7 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 8 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.4 Leading Company Profile: Bres Gygyszergyr Rt
Summary 2 Bres Gygyszergyr Rt: Operational Indicators 2004
3.5 Leading Company Profile: Richter Gedeon Rt
Summary 3 Richter Gedeon Rt: Operational Indicators 2004
3.6 Leading Company Profile: Sanofi-Aventis
Table 9 Sanofi-Synthlabo Chinoin Rt. Turnover 1998-2004
3.7 Leading Company Profile: Teva Magyarorszg Rt
Summary 4 Teva: Operational Indicators 2004
3.8 Retail Distribution
Table 10 Ownership Structure of the Largest Local Wholesalers 2005
Table 11 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 12 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.9 Retailer Activity and Private Label Trends
Table 13 Penetration of Private Label by Sector 2001-2005
3.10 Forecast Market Performance
Table 14 Economic Prognosis (% Growth Compared with Previous Year) 2003-2006
Table 15 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 16 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. NRT SMOKING CESSATION AIDS SALES
4.1 Number of Smokers
Table 17 Number of Smokers by Gender 2000-2005
4.2 Sector Performance
Table 18 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 19 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 20 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 21 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Summary 5 NRT Smoking Cessation Aids: New Product Launches 2004-2005
Table 22 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 23 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
5. DEFINITIONS
